Evaluating progress with next-generation techniques across multiple pathologies.
Ask the Experts: Does Early TEVAR Prevent Aneurysmal Degeneration?
Selection criteria, results of studies comparing medical therapy with TEVAR, and what future studies should seek to evaluate.
With William J. Quinones-Baldrich, MD; Eric L.G. Verhoeven, MD, PhD; Edward Y. Woo, MD; Chandler A. Long, MD; Cynthia K. Shortell, MD; Wei Zhou, MD, FACS; Joshua Leon Black, BS; Wei Guo, MD, PhD; and Cherrie Abraham, MD
The Latest News
Ra Medical Gains IDE to Conduct Pivotal Laser Atherectomy Trial of the DABRA System
January 21, 2020—Ra Medical Systems, Inc. announced approval from FDA that the company has provided sufficient data to support an investigational device exemption trial to evaluate the safety and effectiveness of the company’s DABRA (Destruction of Arteriosclerotic Blockages by laser Radiation Ablation) excimer laser system for use as an atherectomy device for the treatment of peripheral vascular stenoses.
SoundBite Crossing System for Treating Peripheral CTOs Receives FDA Clearance
January 21, 2020—SoundBite Medical Solutions Inc. announced it has received FDA 510(k) clearance for the SoundBite crossing system with active wire technology for use in the treatment of peripheral chronic total occlusions.
Study Shows More Than Half of United States Clinical Trials Fail to Comply With Law on Reporting Results
January 17, 2020—The Lancet announced the publication of a study finding that only 41% of clinical trial results are reported promptly onto the United States trial registry, and one in three trials remain unreported.
PATHFINDER I Registry Will Study AngioDynamics’ Auryon Atherectomy System
January 16, 2020—AngioDynamics, Inc. announced the launch of the PATHFINDER I postmarket registry, which will enroll a total of 100 patients with peripheral artery disease (PAD) treated with the company’s Auryon atherectomy system in a postmarket setting with 36-month follow-up.
Continuing Coverage: Paclitaxel In PAD
New Paclitaxel Meta-Analysis Questions Safety in CLI Population; Concerns Voiced as to Methods
January 15, 2020—In the wake of a year spent scrutinizing the finding of a mortality signal related to paclitaxel-coated balloons and stents in the superficial femoral artery (SFA), a new publication again calls the safety of paclitaxel into question, only this time in the critical limb ischemia (CLI) population.
FDA Grants Breakthrough Device Designation for MedAlliance’s Selution SLR Device for AVF Indications
January 14, 2020—MedAlliance announced that it has received FDA Breakthrough Device designation for the company's Selution SLR sirolimus-eluting balloon catheter for arteriovenous fistula indications.
Insurance Data From Large Patient Cohort Used to Analyze Peripheral Arterial Occlusive Disease in Germany
January 13, 2020—Treatment and comorbidity patterns among patients with peripheral arterial occlusive disease (PAOD) were evaluated using up-to-date longitudinal patient-related data from health insurance claims in Germany.
Continuing Coverage: Paclitaxel In PAD
German Analysis Shows Long-Term Survival With Paclitaxel-Coated Devices Used for Femoropopliteal Artery Revascularization
January 13, 2020—The rapid adoption of the use of paclitaxel-coated devices to treat patients with chronic limb-threatening ischemia (CLTI) has resulted in higher long-term survival, better amputation-free survival, and lower rates of major cardiovascular events, concluded investigators of a retrospective, propensity score-matched cohort analysis of German health insurance claims.
US Device Guide
This Device Guides offers a searchable, comprehensive listing of the available vascular interventional devices in the United States.
European Device Guide
This Device Guides offers a searchable, comprehensive listing of the available vascular interventional devices in Europe.
Most Read Articles
Nine Months Later… An Interview With Konstantinos Katsanos, MD
Dr. Katsanos's thoughts regarding the vascular community's reaction to his group's meta-analysis, the potential influence of follow-up and adjudication variables, non-SFA applications, and what comes next.
With Konstantinos Katsanos, MSc, MD, PhD, EBIR
Dialysis Access Coding Essentials, Recent Changes, and Location Distinctions
Vascular Coding Updates for 2019
New Technologies Put the Thrill Back in Dialysis Access
How Do Emerging Technologies in AV Access Fit Within the Current Economic Climate of Your Practice?
Optimal Medical Therapy for CLI: Recent Advances and the Need for More Data
Critical Limb Ischemia: A Threat to Life and Limb
Next on the Neurointerventional Horizon
Pearls and Pitfalls: Radial First for Neurointervention
Mentors and Protégés: Conversations on Career and Craft With Robert J. Lewandowski, MD, FSIR
Update on Treatment of Cancer-Associated Thrombosis
Roundtable Discussion: Incorporating TRA Into Your Lower Extremity Interventional Practice
Transbrachial Access for Stenting of Femoropopliteal Lesions
Building a Multidisciplinary Aortic Center
Controversies in Dissection Repair: Addressing Paraplegia